Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Background: Although primarily characterised as a motor disorder, Parkinson's Disease (PD) also presents with non-motor symptoms, including cognitive decline and affective dysfunction, which are major predictors of quality of life and mortality for individuals. However, factors associated with these non-motor symptom trajectories remain under-characterised. Purpose: This study aimed to investigate...
BACKGROUND: Fingernail metabolomics provides a novel, non-invasive platform that captures long-term biochemical fluctuations for identifying reliable biomarkers for dementia and mild cognitive impairment (MCI) due to Alzheimer's disease (AD). METHODS: A total of 199 participants were enrolled and stratified according to Clinical Dementia Rating (CDR) scores (0, 0.5, 1, 2, and 3). Fingernail clippi...
Accurate and early diagnosis of Alzheimer's Disease (AD) is crucial for timely interventions and treatment advancement. Functional Magnetic Resonance ...
Dementia represents a rapidly rising global health challenge as a progressive neurodegenerative disease with few options for disease-modifyingtreatmen...
Recent advances in our understanding of non-cell-autonomous mechanisms in neurodegenerative diseases (NDDs) have highlighted microglial dysfunction as...
Parkinson's disease (PD) is a prevalent neurodegenerative disorder worldwide, often progressing to mild cognitive impairment (MCI) and dementia. Clini...
The progression of Alzheimer's disease is relentless, leading to a worsening of mental faculties over time. Currently, there is no remedy for this ill...
Dementia is a degenerative and chronic disorder, increasingly prevalent among older adults, posing significant challenges in providing appropriate car...
Language difficulties are common in school-age children but their etiology is often unknown. Although neural underpinnings of language have been well-...
Process scores in neuropsychological tests add incremental validity for detecting non-normative cognitive aging trajectories. However, process scores...
Dementia, a neurological disorder, can cause cognitive decline due to damage to the brain. Our study aims to contribute to the development of computer...
Dipeptidyl peptidase-IV (DPP-IV) inhibitors play a critical role in the treatment of diabetes and metabolic diseases. This study combines computationa...
Alzheimer's Disease (AD) is a progressive neurodegenerative disorder marked by neuronal loss, leading to cognitive and behavioral decline. With the ag...
Neurological diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis, pose a significant global health challenge due to t...
BACKGROUND: Delays in the diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) contribute to the significant morbidity of the condition, especi...
BACKGROUND: The complex pathogenesis of Alzheimer's disease (AD) has resulted in limited current biomarkers for its classification and diagnosis, nece...
INTRODUCTION: Early-onset Alzheimer's disease (EOAD) population is a clinically, genetically and pathologically heterogeneous condition. Identifying b...
Accurately predicting cognitive scores based on structural MRI holds significant clinical value for understanding the pathological stages of dementia ...
Machine Learning (ML) is a promising approach for predicting outcomes of youth anxiety treatments. To this end, data from nine randomized controlled t...
Parkinson's disease (PD), a progressive neurodegenerative disorder, affects millions globally, with cognitive impairment as a significant non-motor co...